Imported gluten-free foods: free of gluten?
Author: Geoffrey M Forbes
Published online: 15 June 2015
To the Editor: The recent hepatitis A outbreak associated with imported berries has brought the problem of imported food quality acutely into the public spotlight. By contrast, the serious adverse effects for many people with coeliac disease of non-compliant imported foods being labelled “gluten-free” (GF) is more insidious and less easily assessed.
Concern has previously been expressed about proposals to raise the amount of gluten permitted in GF foods.1 In Australia, the current standard for claiming that a food is “gluten-free” is that it contains “no detectable gluten”;2 on the basis of the limits of current laboratory test sensitivity, this equates to less than 3 parts per million (ppm).
Closely aligned with this concern is the fact that imported food labelled “GF” may comply with standards in the country of manufacture but not with tighter Australian standards. For example, “GF” in Europe and North America indicates gluten levels of less than 20 ppm; accordingly, GF-labelled foods imported from these regions may contain detectable gluten. Further, gluten-level testing of GF-labelled foods is not mandatory in the United States;3 in one report, 20% of US foods labelled “GF” did not comply with the Food and Drug Administration standard.4
Governance of food regulation in Australia is unfortunately complex. Food Standards Australia New Zealand set food standards federally; individual states set laws based on the federal standards; local government health officials implement state laws and monitor compliance. The Australian Competition and Consumer Commission, responsible for consumer law, has also contributed to food regulation and compliance. Further, the federal Department of Agriculture has responsibility for regulating imported foods. Local importers and retailers should also facilitate food safety.
Testing of imported foods labelled “GF” is ad hoc, lacking coordination across multiple jurisdictions, and is hampered by financial constraints. There is a tendency for organisations to suggest that the responsibility for compliance lies elsewhere. Enhanced transparency of laboratory food testing outcomes is required, for there are scant published data that assure the consumer about food code compliance for foods labelled “GF”. It is to be hoped that some good will come of the hepatitis A food contamination incident, by providing the impetus for significant change in the governance of Australian food safety.
Competing interests
No relevant disclosures.
References
- Forbes GM. Modifying the gluten-free threshold for foods: first do no harm. Med J Aust 2013; 199: 393. _Ref420486879
- Australian Government. Australia New Zealand Food Standards Code — Standard 1.2.8 — Nutrition information requirements. October 2012. (Federal Register of Legislative Instruments, F2012C00218.) http://www.comlaw.gov.au/Details/F2012C00218 (accessed Feb 2015).
- United States Food and Drug Administration. Questions and answers: Gluten-free food labeling final rule. August 2014. http://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/allergens/ucm362880.htm (accessed Feb 2015).
- Lee HJ, Anderson Z, Ryu D. Gluten contamination in foods labeled as “gluten free” in the United States. J Food Prot 2014; 77: 1830-1833. _Ref420486930
Early-Onset Colorectal Cancer With Liver-Only Metastases: A Retrospective Cohort Study Integrating Prospectively Collected Real-World Clinical and Molecular Data From an Australian National Database (2009–2024) to Guide Treatment Planning
Savio G. Barreto, Christos S. Karapetis, Shahid Ullah, Matthew Burge, Susan Caird, Angus Campbell, Azim Jalali, Ross Jennens, Muhammad A. Khattak, Belinda Lee, Stephanie H. Lim, Shehara Mendis, Louise Nott, Timothy J. Price, Jeremy D. Shapiro, Jeanne Tie, Javier Torres, Colin Williams, Rachel Wong, Vanessa Wong, Peter Gibbs
Australian Pathways for Specialist Pain Management and Early Palliative Care for People With Pancreatic Cancer: Developed Using a Community Consensus Approach
Jennifer Philip, Melanie R. Lovell, Kylee Bellingham, Gail Garvey, Gregory B. Crawford, Nicole M. Rankin, Kara Burns, Isabel Young, Vivienne Milch, Dorothy Keefe, Katrina Anderson, James Lawson, Meinir Krishnasamy
Cause‐specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007–22: a retrospective cohort study
Vikas Bhasker, Jessica R Fong, Paul J Clark, Gunter F Hartel, Richard Skoien, James O’Beirne, Elizabeth E Powell, Patricia C Valery
Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations
Jacob George, Nicole L Allard, Stuart K Roberts, Leon A Adams, Jane Davies, Behzad Hajarizadeh, Jennifer H MacLachlan, Suzanne E Mahady, Rosalie Altus, Catherine Brown, David C Fry, Belinda Greenwood‐Smith, Natali Smud, Patricia C Valery, Nafisa Yussf, Kate Broun, Denise Campbell, Karen Canfell, Chelsea Carle Harrison, Victoria Freeman, Paul Grogan, Catherine Holliday, Suzanne Hughes, Anna Kelly, Cathelijne Kemenade, Claire Latumahina, Amanda McAtamney, Megan Varlow, Joachim Worthington, Susan Yuill, Eleonora Feletto
Assessment of metabolic dysfunction‐associated fatty liver disease in primary care: a consensus statement summary
Leon A Adams, William W Kemp, Kate R Muller, Elizabeth E Powell, Stuart K Roberts, Luis Calzadilla Bertot, Stephanie Best, Gary Deed, Jon D Emery, Samantha L Hocking, Graham R Jones, John S Lubel, Sinead Sheils, Stephen M Twigg, Gerald F Watts, Jacob George
Treatment outcomes for people with hepatitis C referred to tertiary care in Victoria, 2021–22: a retrospective observational study
Elly Layton, Nicole Matthews, Brendan Quinn, Nasra Higgins, Gabrielle Lindeman, Mielle Abbott, Jennifer MacLachlan, Elizabeth Birbilis, Margaret E Hellard, Joseph Doyle, Benjamin C Cowie, Mark Stoové